Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5.

Dennehy KM, Broszeit R, Garnett D, Durrheim GA, Spruyt LL, Beyers AD.

Eur J Immunol. 1997 Mar;27(3):679-86.

PMID:
9079809
2.

Thymocyte activation induces the association of the proto-oncoprotein c-cbl and ras GTPase-activating protein with CD5.

Dennehy KM, Broszeit R, Ferris WF, Beyers AD.

Eur J Immunol. 1998 May;28(5):1617-25.

3.

Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.

Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA.

Eur J Immunol. 1995 Oct;25(10):2978-84.

PMID:
7589101
4.

Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5.

Dennehy KM, Ferris WF, Veenstra H, Zuckerman LA, Killeen N, Beyers AD.

Int Immunol. 2001 Feb;13(2):149-56.

PMID:
11157848
5.
6.

Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.

Susa M, Rohner D, Bichsel S.

Biochem Biophys Res Commun. 1996 Mar 27;220(3):729-34.

PMID:
8607833
8.
9.

Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase.

Chen HC, Appeddu PA, Isoda H, Guan JL.

J Biol Chem. 1996 Oct 18;271(42):26329-34.

10.

Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases.

Vilà JM, Gimferrer I, Padilla O, Arman M, Places L, Simarro M, Vives J, Lozano F.

Eur J Immunol. 2001 Apr;31(4):1191-8.

11.

PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl.

Jain SK, Susa M, Keeler ML, Carlesso N, Druker B, Varticovski L.

Blood. 1996 Sep 1;88(5):1542-50.

14.

Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases.

Schlaepfer DD, Hunter T.

Mol Cell Biol. 1996 Oct;16(10):5623-33. Erratum in: Mol Cell Biol 1996 Dec;16(12):7182-4.

15.

In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.

Ottinger EA, Hui TY, Man Z, Barany G, Bernlohr DA.

Int J Pept Protein Res. 1995 Nov;46(5):346-53.

PMID:
8567177
16.

Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain.

Haefner B, Baxter R, Fincham VJ, Downes CP, Frame MC.

J Biol Chem. 1995 Apr 7;270(14):7937-43.

17.
18.

Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.

Gilmer T, Rodriguez M, Jordan S, Crosby R, Alligood K, Green M, Kimery M, Wagner C, Kinder D, Charifson P, et al.

J Biol Chem. 1994 Dec 16;269(50):31711-9.

19.

Functional requirement of tyrosine residue 429 within CD5 cytoplasmic domain for regulation of T cell activation and survival.

Mier-Aguilar CA, Vega-Baray B, Burgueño-Bucio E, Lozano F, García-Zepeda EA, Raman C, Soldevila G.

Biochem Biophys Res Commun. 2015 Oct 23;466(3):381-7. doi: 10.1016/j.bbrc.2015.09.033. Epub 2015 Sep 9.

PMID:
26363459
20.

Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.

Pleiman CM, Hertz WM, Cambier JC.

Science. 1994 Mar 18;263(5153):1609-12.

PMID:
8128248

Supplemental Content

Support Center